What the FDA labels say about taking them together
Ceftazidime and furosemide
Ceftazidime's FDA label of May 4, 2026 names furosemide in its drug interactions section; the furosemide labels PlainMeds reads (4) do not name ceftazidime.
Check it at the source: the ceftazidime FDA label on DailyMed (effective May 4, 2026, Hospira, Inc.); the furosemide FDA label on DailyMed (effective September 30, 2025, Validus Pharmaceuticals LLC).
What does the ceftazidime label say about furosemide?
Ceftazidime label, drug interactionsDrug Interactions Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibacterial drugs or potent diuretics such as furosemide.
Source: FDA drug label (TAZICEF), Hospira, Inc., effective May 4, 2026 (SPL set 40d48c5d-650e-461b-a67b-7e65772d1b92), via openFDA; the full label on DailyMed
What does the furosemide label say about ceftazidime?
Furosemide's label (effective September 30, 2025) and its 3 other brand-application labels do not name ceftazidime in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Lasix), Validus Pharmaceuticals LLC, effective September 30, 2025 (SPL set 2c9b4d8f-0770-482d-a9e6-9c616a440b1a), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Ceftazidime | Furosemide | |
|---|---|---|
| Labeled for | Bacterial infections | Heart failure, High blood pressure, Edema (fluid retention) |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $3.70 per vial 1 g vial | $0.490 per mL 20 mg/2 mL vial |
| Shortage now | A presentation being discontinued | In shortage |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once